Synthesis and anti-herpes virus activity of 2'-deoxy-4'-thiopyrimidine nucleosides. 1996

S G Rahim, and N Trivedi, and M V Bogunovic-Batchelor, and G W Hardy, and G Mills, and J W Selway, and W Snowden, and E Littler, and P L Coe, and I Basnak, and R F Whale, and R T Walker
Wellcome Research Laboratories, Beckenham, Kent, U.K.

A series of 5-substituted 2'-deoxy-4'-thiopyrimidine nucleosides was synthesized and evaluated as potential antiviral agents. A number of analogues such as 2'-deoxy-5-propyl-4'-thiouridine (3ii), 2'-deoxy-5-isopropyl-4'-thiouridine (3iii), 5-cyclopropyl-2'-deoxy-4'-thiouridine (3iv), 2'-deoxy-4'-thio-5-vinyluridine (3viii), and 5-(2-chloroethyl)-2'-deoxy-4'-thiouridine (3xx) were found to be highly active against herpes simplex virus type-1 (HSV-1) and varicella zoster virus (VZV) in vitro with no significant cytotoxicity. The compound with the broadest spectrum of activity was 2'-deoxy-5-ethyl-4'-thiouridine (3i) which showed significant activity against HSV-1, HSV-2, and VZV.

UI MeSH Term Description Entries
D010948 Viral Plaque Assay Method for measuring viral infectivity and multiplication in CULTURED CELLS. Clear lysed areas or plaques develop as the VIRAL PARTICLES are released from the infected cells during incubation. With some VIRUSES, the cells are killed by a cytopathic effect; with others, the infected cells are not killed but can be detected by their hemadsorptive ability. Sometimes the plaque cells contain VIRAL ANTIGENS which can be measured by IMMUNOFLUORESCENCE. Bacteriophage Plaque Assay,Assay, Bacteriophage Plaque,Assay, Viral Plaque,Assays, Bacteriophage Plaque,Assays, Viral Plaque,Bacteriophage Plaque Assays,Plaque Assay, Bacteriophage,Plaque Assay, Viral,Plaque Assays, Bacteriophage,Plaque Assays, Viral,Viral Plaque Assays
D011741 Pyrimidine Nucleosides Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES. Nucleosides, Pyrimidine
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014709 Vero Cells A CELL LINE derived from the kidney of the African green (vervet) monkey, (CHLOROCEBUS AETHIOPS) used primarily in virus replication studies and plaque assays. Cell, Vero,Cells, Vero,Vero Cell
D018139 Simplexvirus A genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE, consisting of herpes simplex-like viruses. The type species is HERPESVIRUS 1, HUMAN. Herpes Simplex Virus,Herpesvirus 1, Saimiriine,Herpesvirus 1, Saimirine,Herpesvirus 16, Cercopithecine,Marmoset Virus,Cercopithecine Herpesvirus 16,Herpes Labialis Virus,Herpes-T Virus,Herpesvirus 1 (alpha), Saimirine,Herpesvirus Hominis,Herpesvirus Papio 2,Herpesvirus Platyrhinae,Marmoset Herpesvirus,Saimiriine Herpesvirus 1,Herpes Labialis Viruses,Herpes Simplex Viruses,Herpes T Virus,Herpes-T Viruses,Herpesvirus Homini,Herpesvirus, Marmoset,Herpesviruses, Marmoset,Homini, Herpesvirus,Hominis, Herpesvirus,Labialis Virus, Herpes,Labialis Viruses, Herpes,Marmoset Herpesviruses,Marmoset Viruses,Platyrhinae, Herpesvirus,Saimirine Herpesvirus 1,Simplexviruses,Virus, Herpes Labialis,Viruses, Herpes Labialis

Related Publications

S G Rahim, and N Trivedi, and M V Bogunovic-Batchelor, and G W Hardy, and G Mills, and J W Selway, and W Snowden, and E Littler, and P L Coe, and I Basnak, and R F Whale, and R T Walker
January 2009, Nucleic acids symposium series (2004),
S G Rahim, and N Trivedi, and M V Bogunovic-Batchelor, and G W Hardy, and G Mills, and J W Selway, and W Snowden, and E Littler, and P L Coe, and I Basnak, and R F Whale, and R T Walker
January 1999, Nucleosides & nucleotides,
S G Rahim, and N Trivedi, and M V Bogunovic-Batchelor, and G W Hardy, and G Mills, and J W Selway, and W Snowden, and E Littler, and P L Coe, and I Basnak, and R F Whale, and R T Walker
January 1996, Journal of medicinal chemistry,
S G Rahim, and N Trivedi, and M V Bogunovic-Batchelor, and G W Hardy, and G Mills, and J W Selway, and W Snowden, and E Littler, and P L Coe, and I Basnak, and R F Whale, and R T Walker
August 1991, Journal of medicinal chemistry,
S G Rahim, and N Trivedi, and M V Bogunovic-Batchelor, and G W Hardy, and G Mills, and J W Selway, and W Snowden, and E Littler, and P L Coe, and I Basnak, and R F Whale, and R T Walker
October 1999, Nucleosides & nucleotides,
S G Rahim, and N Trivedi, and M V Bogunovic-Batchelor, and G W Hardy, and G Mills, and J W Selway, and W Snowden, and E Littler, and P L Coe, and I Basnak, and R F Whale, and R T Walker
January 2001, Nucleosides, nucleotides & nucleic acids,
S G Rahim, and N Trivedi, and M V Bogunovic-Batchelor, and G W Hardy, and G Mills, and J W Selway, and W Snowden, and E Littler, and P L Coe, and I Basnak, and R F Whale, and R T Walker
January 2004, Nucleosides, nucleotides & nucleic acids,
S G Rahim, and N Trivedi, and M V Bogunovic-Batchelor, and G W Hardy, and G Mills, and J W Selway, and W Snowden, and E Littler, and P L Coe, and I Basnak, and R F Whale, and R T Walker
August 1997, Journal of medicinal chemistry,
S G Rahim, and N Trivedi, and M V Bogunovic-Batchelor, and G W Hardy, and G Mills, and J W Selway, and W Snowden, and E Littler, and P L Coe, and I Basnak, and R F Whale, and R T Walker
March 1989, Antimicrobial agents and chemotherapy,
S G Rahim, and N Trivedi, and M V Bogunovic-Batchelor, and G W Hardy, and G Mills, and J W Selway, and W Snowden, and E Littler, and P L Coe, and I Basnak, and R F Whale, and R T Walker
January 2005, Nucleosides, nucleotides & nucleic acids,
Copied contents to your clipboard!